FRI0221 Does Seropositivity Influence Differentially Drug Discontinuation of Biologic Antirheumatic Agents With Non-Anti-TNF Mode of Action?

doi 10.1136/annrheumdis-2017-eular.6006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

THU0174 Drug Retention of Tofacitinib Versus Biologic Antirheumatic Agents in Rheumatoid Arthritis: Observational Data From the Swiss SCQM Registry

2017English

Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients With Rheumatoid Arthritis

Genes
Genetics
2018English

FRI0754-HPR Impact of Corticosteroid Utilization on Biologic Disease-Modifying Antirheumatic Drug Initiation Among Patients With Rheumatoid Arthritis

2017English

Studies on the Mode of Action of Non-Steroid Anti-Inflammatory Drugs.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1972English

High Incidence of Disease Recurrence After Discontinuation of Disease-Modifying Antirheumatic Drug Treatment in Patients With Psoriatic Arthritis in Remission

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2013English

Site of Analgesic (Anti-Writhing) Action of a Non-Steroidal Anti-Inflammatory Drug, Tolmetin Sodium

Ensho
1981English

Editorial: Therapeutic Drug Monitoring for Anti-TNF Agents-Has It All Been Said? Author's Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Genetic Markers Predict Primary Non-Response and Durable Response to Anti-TNF Biologic Therapies in Crohn’s Disease

American Journal of Gastroenterology
HepatologyGastroenterology
2016English

AB1031 Anti-Drug Antibodies: Assay Performance in Patients Treated With ANTI-TNF Biodrugs

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy